Featured Research

from universities, journals, and other organizations

Risk factors for little-known lung infection identified

Date:
March 17, 2014
Source:
University of Illinois at Chicago
Summary:
Severe and sometimes fatal lung disease caused by a group of bacteria in the same family as those that cause tuberculosis is much more common than previously thought, with Caucasians 55 and older at greatest risk, report researchers. Nontuberculous mycobacteria (NTM) include more than 150 types of bacteria that can infect the lungs when inhaled. Unlike tuberculosis, NTM is not contagious and cannot spread from person to person. The infection is treatable, but antibiotic therapy is expensive and can take up to two years. Rates of infection have climbed significantly since the 1980s.

Dean Schraufnagel, professor of medicine, and Mehdi Mirsaeidi, pulmonary and critical care fellow.
Credit: Roberta Dupuis-Devlin

Severe and sometimes fatal lung disease caused by a group of bacteria in the same family as those that cause tuberculosis is much more common than previously thought, with Caucasians 55 and older at greatest risk, report researchers from the University of Illinois at Chicago College of Medicine.

The study is published online March 14 in PLOS ONE.

Nontuberculous mycobacteria (NTM) include more than 150 types of bacteria, found in water and soil, that can infect the lungs when inhaled. Unlike tuberculosis, NTM is not contagious and cannot spread from person to person. The infection is treatable, but antibiotic therapy is expensive and can take up to two years.

Rates of infection have climbed significantly since the 1980s. But while researchers suspect that deaths caused by NTM have also risen, the mortality rate and associated risk factors have remained unknown.

"There have been some studies suggesting that lung infections caused by NTM have been increasing in North America, especially in people aged 50 years or older," says Dr. Mehdi Mirsaeidi, UIC pulmonary and critical care fellow and lead author of the paper. "We wanted to know more about exactly who is most at risk for acquiring NTM and dying from it, so that we could develop strategies for preventing infection."

The researchers looked at the cause of deaths in the U.S. between 1999 and 2010. NTM was listed as immediate cause of death for 2,990 people -- of whom 87 percent were 55 or older, 85 percent were white, and 52 percent were female.

The researchers also found that the age-adjusted NTM mortality rates were uneven across the U.S. Residents of Hawaii, the state with the highest rate, were almost nine times more likely to die from NTM than were residents of Michigan, with the lowest rate. Louisiana, Arizona, South Carolina, North Carolina and Florida also had high NTM mortality rates. "The reason for this variation is unknown," Mirsaeidi said.

NTM-related deaths also correlated with smoking, cancer, HIV infection, and chronic obstructive pulmonary disease.

But the strongest association was between NTM disease death and older age, Mirsaeidi said. "We expect to see the numbers of deaths attributable to NTM rise as the population continues to age and the numbers of older Americans continue to grow."

"People and physicians need to be aware of NTM, especially as we see more of it, and because it can look like a lot of other pulmonary diseases," Mirsaeidi said. Patients usually present with a cough, and correct diagnosis can take years, he said.

"Having a better understanding of the risk factors associated with NTM will give us a better chance of diagnosing it faster. This is important, because it's largely a curable infection."


Story Source:

The above story is based on materials provided by University of Illinois at Chicago. Note: Materials may be edited for content and length.


Journal Reference:

  1. Mehdi Mirsaeidi, Roberto F. Machado, Joe G. N. Garcia, Dean E. Schraufnagel. Nontuberculous Mycobacterial Disease Mortality in the United States, 1999–2010: A Population-Based Comparative Study. PLoS ONE, 2014; 9 (3): e91879 DOI: 10.1371/journal.pone.0091879

Cite This Page:

University of Illinois at Chicago. "Risk factors for little-known lung infection identified." ScienceDaily. ScienceDaily, 17 March 2014. <www.sciencedaily.com/releases/2014/03/140317103515.htm>.
University of Illinois at Chicago. (2014, March 17). Risk factors for little-known lung infection identified. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140317103515.htm
University of Illinois at Chicago. "Risk factors for little-known lung infection identified." ScienceDaily. www.sciencedaily.com/releases/2014/03/140317103515.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins